Litigation Details for ELLIOTT ASSOCIATES, L.P. v. BURWELL (D.D.C. 2014)
✉ Email this page to a colleague
ELLIOTT ASSOCIATES, L.P. v. BURWELL (D.D.C. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-11-04 |
| Court | District Court, District of Columbia | Date Terminated | 2014-11-25 |
| Cause | 05:551 Administrative Procedure Act | Assigned To | Ketanji Brown Jackson |
| Jury Demand | None | Referred To | |
| Patents | 7,619,004; 7,820,681; 8,097,655; 8,440,722 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ELLIOTT ASSOCIATES, L.P. v. BURWELL
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for ELLIOTT ASSOCIATES, L.P. v. BURWELL (D.D.C. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-11-04 | 1 | See U.S. Patent No. 7,619,004 (“the ’004 patent”); U.S. Patent No. 7,820,681 (“the ’681 patent”); U.S.…U.S. Patent No. 8,097,655 (“the ’655 patent”); U.S. Patent No. 8,440,722 (“the ’722 patent”). … several patents claiming the use of Colcrys®, including the ’655 patent and the ’722 patent. See Complaint…30 months had passed, the patents had expired, or a court found the patents invalid or not infringed. …also identify “the patent number and the expiration date” of any method of use patent “with respect to | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
